GeftiNat (Gefitinib) is indicated as monotherapy for uninterrupted treatment of patients who are having metastatic non-small cell lung cancer.
250mg tablet of GEFTINIB in a day, with or without food works as complete dose, is ideally efficacious for patient with lung cancer. Those who are having problem in swallowing can have dispersed form of table in drinking water. High quality of dose doesn’t carry a good response and this may also cause of increased toxicity. So consult with your doctor before taking the dose.
Some common side effects that may occur as a result of the usage of Geftinat tablets, include - diarrhea, rashes, itching, dry skin and acne. In any case if you persist any of them, you are advised to consult with your doctor straight away.
NOTE : Before administering this drug you are sincerely advised to consult with your health care professional.
Please share your contact details and we will get in touch with you soon.